Targeting HspX of Mycobacterium tuberculosis: Advances in diagnostics, treatment, and vaccine development

This publication has 100 references indexed in Scilit:

• Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis
  Current Microbiology, 2024
• The functions and applications of extracellular vesicles derived from Mycobacterium tuberculosis
  Biomedicine & Pharmacotherapy, 2023
• Hsp16.3 of mycobacterium tuberculosis in exosomes as a biomarker of tuberculosis
  European Journal of Clinical Microbiology & Infectious Diseases, 2021
• A novel aptamer-based test for the rapid and accurate diagnosis of pleural tuberculosis
  Analytical Biochemistry, 2019
• HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview
  Frontiers in Biology, 2018
• Evaluation of Mycotube, a modified version of Lowenstein–Jensen (LJ) medium, for efficient recovery of Mycobacterium tuberculosis (MTB)
  European Journal of Clinical Microbiology & Infectious Diseases, 2017
• Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens
  European Journal of Clinical Microbiology & Infectious Diseases, 2015
• Intraepithelial Lymphocytes: To Serve and Protect
  Current Gastroenterology Reports, 2010
• Comparison of BacT/ALERT 3D, Lowenstein-Jensen medium and Middlebrook 7H10/7H11 biplate for recovering mycobacteria from clinical specimens
  European Journal of Clinical Microbiology & Infectious Diseases, 2005
• Characterization of HLA‐DR‐ and TCR‐binding residues of an immunodominant and genetically permissive peptide of the 16‐kDa protein of Mycobacterium tuberculosis
  European Journal of Immunology, 2004